NUMANS (02530) has announced that the group expects to record an annual net profit after tax of no more than approximately RMB 6 million for the fiscal year ending December 31, 2025. This compares to a net profit after tax of about RMB 74.9 million for the previous fiscal year ended December 31, 2024. The board attributes the anticipated decline in net profit primarily to the following factors: (1) a significant decrease in revenue due to overall consumption downgrading in the Chinese economy; (2) intensified competition in domestic DHA products; and (3) an inventory impairment loss of approximately RMB 19.3 million recognized by the company.